Abstract
Cancer metastasis is a complicated process. For a transformed cell to form a successful metastatic colony, it must in general complete all or most of the well-defined steps that comprise the “metastatic cascade”.1–4 The first step is uncontrolled cell proliferation, characteristic of both benign and malignant tumor cells. Intrinsic or acquired genetic instability, together with various epigenetic factors, generate tumor cell variants that acquire unique phenotypic characteristics that dissociate them from the parent tumor population and thus allow these variants to escape from the “social” constraints imposed by the host. This step confers on these “mutated” tumor cells invasive or metastatic capabilities and is generally considered to be the first step leading to site-specific metastasis. In the next step, tumor cells, in response to various chemoattractants and cytokines derived from the host and/or tumor cells, migrate towards neighboring vasculature or intravasate into the vasculature of the tumor and thus enter the hematogenous or lymphatic circulation. Subsequently, tumor cells travel to and arrest in the microcirculation by specific adherence to the endothelial cells of the target organ. Thereafter, tumor cells induce endothelial cell retraction, exit from circulation (extravasation), interact with the organ-specific extracellular matrix (ECM), proliferate in response to local (“soil”) growth factors, and finally form a metastatic colony. Failure at any one of these steps generally will abort the metastatic process. Completion of every step of the metastatic cascade is subject to a multitude of variable influences, an apparent example being the requirement of angiogenesis for the growth of both primary and secondary tumors.5.6
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Honn, K.V. and Sloane, B.F. Hemostatic Mechanisms and Metastasis. Martinus Nijhoff, Norwell, MA. 1984.
Weiss, L., Orr, F.W. and Honn, K.V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J. 2, 12, 1988.
Honn, K.V., Powers, W.E., and Sloane, B.F., Mechanisms of Cancer Metastasis: Potential Therapeutic Implications. Martinus Nijhoff, Norwell, MA, 1986.
Filder, I.J. and Hart, I.R., Biological diversity in metastatic neoplasms: origins and implications. Science, 217, 998, 1982.
Folkman, J., Watson, K., Ingber, D., and Hanahan, D., Induction of angiogenesis during the transition from hyperplasia to neoplasia, Nature, 339, 58, 1989.
Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327, 1991.
Weiss, L., Orr, F.W., and Honn, K.V., Interactions between cancer and the microvasculature: a rate-regulator for metastasis, Clin. Expl. Metastasis, 7, 127, 1989.
Hart, I.R., Goode, N.T., and Wilson. R.E., Molecular aspects of the metastatic cascade, Biochim. Biophys, Acta., 989, 65, 1989.
Liotta, L.A., Tumor invasion and metastasis: role of the extracellular matrix, Cancer Res., 46, 1, 1986.
Pauli, B.U. and Lee, C.L. Organ preference of metastasis: the role of organ-specifically modulated endothelial cells. Lab. Invest., 58, 379, 1988.
Belloni, P.N. and Tressler, R.J., Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells, Cancer Metastasis Rev., 8, 353, 1990.
Pauli, B.U., Augustin-Voss, H.G., El-Sabban, M.E., Johnson, R.C., and Hammar, D.A., Organ preference of metastasis: the role of endothelial cell adhesion molecules. Cancer Metastasis Rev., 9, 175, 1990.
Nicolson, G.L., Organ specificity of tumor metastasis: role of preferential adhesion, invasion, and of malignant cells at specific secondary sites, Cancer Metastasis Rev., 7, 143, 1988.
Auerbach, R., Pattern of tumor metastasis: organ selectivity in the spread of cancer cells, Lab. Invest., 58, 361, 1988.
Nicolson, G.L., Tumor and host molecules important in the organ preference of metastasis. Semin. Cancer Biol., 2, 143, 1991.
Honn, K.V., Grossi, I.M., Timar, J., Chopra, H., and Taylor, J.D., Platelets and cancer metastasis, in Micro-circulation in Cancer Metastasis, Orr, F.W., Buchanan, M., and Weiss, L., Eds., CRC Press, Boca Raton, FL, 1991, 93.
Honn, K.V., Tang, D.G., and Chen, Y.Q. Platelets and cancer metastasis: more than an epiphenomenon. Semin. Thromb. Hemost., 18, 390, 1992.
Honn, K.V., Tang, D.G., and Crissman, J.D., Platelets and cancer metastasis: a casual relationship? Cancer Metastasis Rev., 11, 325, 1992.
Samuelsson, B., Goldyne, M., Granstrom, E., Hamberg, M., Hammarstrom, S., and Malmstern, C., Prostaglandins and thromboxanes, Annu. Rev. Biochem., 47, 997, 1978.
Needleman, P., Turk, J., Jakschik, B.A., Morrison, A.R., and Lefkowith, J.B., Arachidonic acid metabolism, Annu. Rev. Biochem., 55, 69, 1986.
Piper, P.J. and Samhoun, M.D., Leukotrienes, Br. Med. Bull., 43, 297, 1987.
Spector, A.A., Gordon, J.A., and Moore, S.A., Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid Res., 27, 271, 1988.
Honn, K.V. and Chen, Y.Q., Prostacyclin, hydroxy fatty acids and tumor metastasis, in Prostacyclin: New Perspectives in Basic Research and Novel Therapeutic Indications, Rubanyi, G.M. and Vane, J.R., Eds., Elsevier, Amsterdam, 1995.
Chen, Y.Q., Liu, B., Tang, D.G., and Honn, K.V., Fatty acid modulation of tumor cell-platelet-vessel wall interaction, Cancer Metastasis Rev., 1 I, 389, 1992.
Chang, W.C., Ning, C.C., Lin, M.T., and Huang, J.D., Epidermal growth factor enhances a microsomal 12lipox,ygenase activity in A431 cells, in Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, Nigam, S., Honn, K.V., Marnett, L.J., and Walter, T., Eds., Kluwer Academic, Norwell, MA, 1992, 463.
Glasgow, W.C. and Eling, T.E., Epidermal growth factor regulation of linoleic acid metabolism in Syrian hamster embryo fibroblasts, in Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, Nigam, S., Honn, K.V., Marnett, L.J., and Walden T., Eds., Kluwer Academic, Norwell, MA, 1992, p. 467.
Marier, J.A.M., Hla, T., and Maciag, T., Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem., 265, 10805, 1990.
Kast, R., Furstenberger, G., and Marks, F., Transforming growth factor alpha stimulated phospholipase A2 activity in mouse keratinocytes, in Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, Nigam, S., Honn, K.V., Marnett, L.J., and Walden, T., Eds., Kluwer Academic, Norwell, MA, 1992, 459.
Arita, H., Cytokine-induced phospholipase A2 and its possible relationship to eicosanoid formation, in Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury., Nigam S., Honn, K.V., Marnett, L.J., and Walden, T., Eds, Kluwer Academic, Norwell, MA, 1992, p. 491.
Spector, A.A., Gordon, J.A., Moore, S.A., Hydroxyeicosatetraenoic acids (HETEs)., Prog. Lipid Res. 27, 271, 1988.
Natarajan, R., Gu J, L., Rossi, J., Gonzales, N., L.nting, L., XU, 1., and Nadler, J., Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells., Proc. Natl. Acad. Sci. USA, 90, 4947, 1993.
Kim, J.A., Gu, J., Natarajian, R., Berliner, J.A., and Nadler, J., Evidence that a leukocyte type of 12lipoxygenase is expressed in normal human vascular and mononuclear cells., Clin. Res., 41, 148A, 1983.
Hadjiangapiou, C., and Spector, A.A., 12-hydroxyeicosatetraenoic acid reduces prostacyclin production by endothelial cells., Prostaglandins 31, 1135, 1986.
Sekiya, F., Takagi, J., Usui, T., Kawajiri, K., Kobayashi, Y., Sato, F., and Saito, Y., I2-hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Biochem. Biophys. Res. Commun. 179, 345, 1991.
Hofer, G., Bieglmayer, C.H., Kopp, B., Janish, H., Measurement of eicosanoids in menstrual fluid by the combined use of High pressure chromatography and radio immunoassay., Prostaglandins, 45, 413, 1993.
Wetzka, B., Schafer, W., Scheibel, M., Nusing, R., Zahradnik, H.D., Eicosanoid production by intrauterine tissues before and after labor in short-term tissue culture., Prostaglandins, 45, 571, 1993.
Chang, W.C., Liu, Y.W., Ning, C.C., Suzuki, H., Yoshimoto, T., Yamamoto, S., Induction of arachidonate 12-lipoxygenase mRNA by epidermal growth factor in A43I cells., J. Biol. Chem., 268, 18734, 1993.
Chang, W.C., Ning, C.C, Lin, M.T., Huang, J.D., Epidermal growth factor enhances a microsomal 12lipoxygenase activity in A43I cells., J. Biol. Chem., 267, 3657, 1992.
Chen, Y.Q., Duniec, Z.M., Liu, B., Hagmann, W., Gao, X., Shimoji, K., Marnett, L.J., Johnson, C.R., Honn, K.V., Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res., 54, 1574, 1994.
Hagmann, W., Kagawa, D., Renaud, C., Honn, K.V., Activity and protein distribution of I 2-lipoxygenase in FIEL cells: Induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca’.-dependent translocation to membranes., Prostaglandins, 46, 471, 1993.
Hagmann, W., Maher, R., Honn, K.V., Intracellular distribution, activity, and Ca’tdependent translocation of 12-lipoxygenase in Lewis lung tumor cells. In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, Honn, K.V., Marnett, L.J., and Nigam S., Eds., Plenum Publishing, in press, 1997.
Liu, B., Timar, J., Howlett, J., Diglio, C.A., Honn, K.V., Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C., Cell Regul. 2, 1045, 1991.
Liu, B., Marnett, L.J., Chaudhary, A., Ji, C., Blair, I.A., Johnson, C.R., Diglio, C.A., and Honn, K.V., Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by BI6 amelanotic melanoma cells is a determinant of their metastatic potential. Lab. Invest., 70, 314, 1994.
Honn, K.V., Tang, D.G., Grossi, I., Duniec, Z.M., Timar, J., Renaud, C., Leithauser, M., Blair, I., Johnson, C.R., Diglio C.A., Kimler, V.A., Taylor, J.D., and Marnett, L.J., Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction., Cancer Res., 54, 565, 1994.
Honn, K.V., Nelson, K.K., Renaud, C., Bazaz, R., Diglio, C.A., Timar, J., Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis., Prostaglandins, 44, 413, 1992.
Tang, D.G., Honn, K.V., 12-Lipoxygenase, 12(S)-HETE, and cancer metastasis. Annals New York Acad. Sci., 744, 199, 194.
Timar, J., Chen, Y.Q., Liu, B, Bazaz, R., Taylor, J.D., Honn, K.V., The lipoxygenase metabolite 12(S)HETE promotes allb133 integrin-mediated tumor cell spreading on fibronectin, Int. J. Cancer, 52, 594, 1992.
Honn, K.V., Tang, D.G., Grossi, I.M., Renaud, C., Duniec, Z.M., Johnson, C.R., Diglio, C.A., Enhanced endothelial cell retraction mediated by 12(S)-HETE: A proposed mechanism for the role of platelets in tumor cell metastasis. Exptl. Cell. Res., 210, 1, 1994.
Liotta, L.A., Mandler, R., Murano, G., Katz, D.A., Gordon, R.K., Chiang, P.K., Schiffman, E., Tumor-cell autocrine motility factor. Proc. Natl. Acad. Sci. USA, 83, 3302, 1986.
Watanabe, H., Carmi, R, Hogan, V., Raz, T., Silletti, S., Nabi, I.R., and Raz, A., Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor., J. Biol. Chem., 226, 13442, 1991.
Ruoslahti, E., Giancotti, F.G., Integrins and tumor cell dissemination., Cancer Cells 4, 119, 1989.
Singer, I.J., Scott, S., Kawaka, D.W., Kazazis, D.M., Adhesosomes: specific granules containing receptors for laminin, c3bi, fibrinogen, fibronectin and vitronectin in human polymorphonuclear leukocytes and monocytes., J. Cell. Biol. 109, 3169, 1989.
Chopra, H., Timar, J., Chen, Y.Q., Rong, X.H., Grossi, I.M., Fitzgerald, L.A., Taylor, J.D., and Honn, K.V., The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin allb133 on melanoma cells., Int. J. Cancer, 49, 774, 1991.
Zachary, I., Rozengurt, E., Focal adhesion kinase (p125FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenes., Cell 71, 891, 1992.
Shaller, M.D., Borman, C.A., Cobb, B.S., Vines, R.R., Reynolds, A.B., and Parsons, T.J., pp125F4K, a structurally distinctive protein-tyrosine kinase associated with focal adhesions, Proc. Natl. Acad. Sci. USA, 89, 5192, 1992.
Guan, J.L., and Shalloway, D., Regulation of focal adhesion-as-associated protein tyrosine kinase by both cellular adhesion on oncogenic transformation., Nature, 358, 690, 1992.
Grossi, I.M., Fitzgerald, L.A., Unbarger, L.A., Nelson, K.D., Diglio, C.A., Taylor, J.D., and Honn, K.V., Bi-directional control of membrane expression and/or activation of the tumor cell IRGpIIB/llla receptor and tumor cell adhesion by lipoxygenase products of arachidonic and linoleic acid., Cancer Res. 49, 1029, 1989.
Chang, Y.S., Chen, Y.Q., Timar, J., Grossi, I.M., Fitzgerald, L.A., Diglio, C.A., and Honn, K.V., Increased expression of allbß3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability., Int. J. Cancer, 51, 445, 1992.
Chen, Y.Q., Gao, X., Timar, J., Tang, D.G., Grossi, I.M., Chelladurai, M., Kunicki, T.J., Fligiel, S.E.G., Taylor, J.D., and Bonn, K.V., Identification of the allb133 integrin in murine tumor cells., J. Biol. Chem., 267, 17314, 1992.
Chopra, H., Timar, J., Rong, X., Grossi, I.M., Hatfield, J.S., Fligiel, S.E.G., Finch, C.A., Taylor, J.D., and Honn, K.V., Is there a role for the tumor cell integrin atlbf33 and cytoskeleton in tumor cell-platelet interaction?, Clin. Exptl. Metastasis, I0, 125, 1992.
Timar, J., Silletti, S., Bazaz, R., Raz, A., and Honn, K.V., Regulation of melanoma-cell motility by the lipoxygenase metabolite 12(S)-HETE., Int. J. Cancer, 55, 1003, 1993.
Silletti, S., and Raz, A., Autocrine motility factor (AMF) is a growth factor., Biochem. Biophys. Res. Commun., 1994, 446, 1993.
Liu, B., Maher, R.J., Hannun, Y.A., Porter, A.T., and Honn, K.V., I2(S)-HETE increases in invasive potential of prostate tumor cells through selective activation of PKCa., J. Natl. Cancer Inst., 86, 1145. 1994.
Honn, K.V., Timar, J., Rozhin, J., Bazaz, R., Sameni, M., Ziegler, G., and Sloane, B.F., A lipoxygenase metabolite, I 2(S)-HETE, stimulates protein kinase C-mediated release of cathespin B from malignant cells., Exptl. Cell. Res., 214, 120, 1994.
Schmitt, M. and Graff, J.H., Tumor-associated proteases., Fibrinolysis, 6, 3, 1992.
Sloane, B.F., Moin, K. Sameni, M., Tait, L.R., Rozhin, J., and Ziegler, J., Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene., J. Cell Sci., 107, 373, 1994.
Sloane, B.F., Moin, K., Krepela, E. and Rozhin, J., Cathepsin B and its endogenous inhibitors: the role in tumor cell malignancy., Cancer Metastasis Rev., 9, 333, 1990.
Sloane, B.F., Rozhin, J., Johnson, K., Taylor, J., Crissman, J.D., and Honn, K.V., Cathepsin B: association with plasma membrane in metastatic tumors., Proc. Natl. Acad. Sci. USA, 83, 2483, 1986.
Sloane, B.F., Rozhin, J.R., Gomez, A.P., Grossi, I.M., and Honn, K.V., Effects of I2-hydroxyeicosatetraenoic acid on release of cathepsin B and cysteine proteinase inhibitors from malignant melanoma cells. In: Honn, K.V., Marnett, L.J., Nigam, S., Walden, T.L., Eds., Eicosanoids and Other Bioactive Lipids in Cancer and Radiation Injury., Kluwer, Boston, MA, p. 373, 1991.
Timar, J., Tang, D.G., Bazaz, R., Haddard, M.M., Kimler, V.A., Taylor, J.D., T and Honn, K.V., PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in BI6a melanoma cells., Cell Motil. Cytoskel., 26, 49, 1993.
Tang, D.G., and Honn, K.V., Role of protein kinase C and phosphatases in I2(S)-HETE-induced tumor cell cytoskeletal reorganization. In: Honn, K.V., Marnett, L.J., Nigam, S., Eds., Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury., Kluwer, Boston, MA, in press, 1997.
Piomelli, D., Volterra, A., Dale, N., Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of aplysia sensory cells., Nature, 328, 38, 1987.
Nadler, J.L, Natarajan, R., and Stem, N., Specific action of the lipoxygenase pathway in mediating angiotension II-induced aldosterone synthesis in isolated adrenal glomerula cells, J. Clin. Invest., 80, 1763, 1987.
Chan, C.C., Duhamel, L., and Ford-Hutchinson, A., Leukotriene B4 and 12- hydroxyeicosatetraenoic acid stimulate epidermal proliferation in vivo in the guinea pig., J. Invest. Dermatol., 85, 333, 1985.
Antonipillai, I., I2-Lipoxygenase products are potent inhibitors of prostacyclin-induced renin release., Proc. Soc. Exp. Biol. Med., 194, 224, 1990.
Etingin, O.R., and Hajjar, D.P., Evidence for cytokine regulation of cholesterol metabolism in herpes viral-infected arterial cells by the lipoxygenase pathway., J. Lipid Res., 31, 299, 1990.
Tang, D.G., Diglio, C.A., and Honn, K.V., Transcriptional activation of endothelial cell integrin alpha, by protein kinase C activator 12(S)-HETE., J. Cell. Sci., 108, 2679, 1995.
Honn, K.V., Tang, D., Grossi, I.M., Duniec, Z.M., Timar, J., Renaud, C., Leithauser, M., Blair, I., Diglio, C.A., Taylor, J.D., and Mamett, L.J., Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction., Cancer Res., 54, 565, 1994.
O’Brian, C.A., and Ward, N.E., Biology of protein kinase C family., Cancer Metastasis Rev., 8, 199, 1989.
Liu, B., Khan, W.A., Hannun, Y.A., Timar, J., Taylor, J.D., Lundy, S., Butovich, I., and Honn, K.V., 12(S)HETE and 13(S)-HODE regulation of protein kinase Ca in melanoma cells: role of receptor mediated hydrolysis of inositol phospholipids., Proc. Natl. Acad. Sci. USA, 92, 9323, 1995.
Honn, K.V., Tang, D.G., Gao, Z., Butovich, I.A., Liu, B., Timar, J., and Hagmann, W., I2-Lipoxygenases and 12(S)HETE: role in cancer metastasis., Cancer Metastasis Rev., 13, 365, 1994.
Liu, B., Renaud, C., Nelson, K.K., Chen, Y.Q., Bazaz, R., Kowynia, J., Timar, J., Diglio C.A., and Honn, K.V., Protein kinase C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization., Int. J. Cancer, 52, 147, 1992.
Berridge, M.J. and Irvine, R.F., Inositol phosphates and cell signaling., Nature, 341, 197, 1989.
Cho, Y., and Ziboh, V.A., 13-Hydroxyocatadecaenoic acid reverse epidermal hyperproliferaiton via selective inhibition of protein kinase C-b activity. Biochem. Biophys. Res. Commun., 201, 257, 1994.
Gross E., Ruzicka, T., Restorff, B.V., Stolz, W., and Klotz, K.N., High-affinity binding and lack of growth-promoting activity of 12(S)hydroxyeicosatatraenoic acid (12[S]HETE) in a human epidermal cell lines., J. Invest. Dermatol., 94, 446, 1990.
Croset, M., and Lagarde, M., Stereospecific inhibition of PGHZ induced aggregation by lipoxygenase products of eicosaenoic acids., Biochem. Biophys. Res. Commun., 112, 878, 1983.
Fonlupt, P., Croset, M., and Lagarde, M., I2(S)-HETE inhibits the binding of PGH,/TXA, receptor ligands in human platelets, Thromb. Res., 63, 239, 1991.
Herbertsson, H. and Hammarstrom, S., High-affinity binding sites for 12(S)hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)HETE) in carcinoma cells, FEBS Lett., 298. 249, 1992.
Herbertsson, H. and Hammarstrom, S., Cytosolic 12(S)hydroxy-5,8,10,14- eicosatetraenoic acid binding sites in carcinoma cells. In: Honn, K.V., Mamett, L.J., Nigam, S., Eds., Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury., Kluwer Acad. Publ., Norwell, MA, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tang, K., Honn, K.V. (1997). Lipoxygenase Metabolites and Cancer Metastasis. In: Dietary Fat and Cancer. Advances in Experimental Medicine and Biology, vol 422. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2670-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2670-1_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3282-2
Online ISBN: 978-1-4757-2670-1
eBook Packages: Springer Book Archive